Ex-Pharma Exec Seeks Leniency After SEC Contempt Plea
By Brian Dowling · July 29, 2024, 1:36 PM EDT
A former pharmaceutical executive is hoping to avoid jail after his use of an alias to circumvent a U.S. Securities and Exchange Commission ban on finance work landed him a criminal...
To view the full article, register now.